SATURDAY, SEPTEMBER 24, 2016

FIND announces three new appointments to board of directors

The Foundation for Innovative New Diagnostics, an organization dedicated to providing diagnostic tests to the poorest areas of the world, announced three new appointments on Friday to its board of directors.

FIND appointed Deepak Gupta from India, Carlos Morel from Brazil and Michael Watson from France to its board. Gupta spent 37 years in the Indian Administrative Service and retired as India's secretary of the Ministry of New and Renewable Energy. Morel is currently the director for the Center of Technology Development in Health with the Oswaldo Cruz Foundation. Watson is the team leader for global immunization policy and advocacy with Sanofi Pasteur.

"I am delighted to welcome these new members to the FIND family," Mark Kessel, the current chair of FIND's board of directors, said. "Each has a long and impressive experience in global health and will bring valuable expertise to the organization."

Gupta spent a decade in the health sector and was instrumental in India's fast expansion of the Revised National TB Control Programme. He also advised the World Health Organization in Delhi to oversee the expansion of the RNTCP. Additionally, Gupta represented India in the Global Fund to Fight AIDS, Tuberculosis and Malaria and the Stop TB Alliance.

Morel actively participated in the creation of multiple global programs of research and development for neglected disease, including the Global Alliance for TB Drug Development, Medicines for Malaria Venture and the Global Forum for Health Research. He also witnessed the establishment of FIND during the 2003 World Health Assembly.

Watson led teams that developed and licensed Pediacel in the U.K. and Gardasil in Europe. He also oversaw the licensure of a smallpox vaccine and the research and development of vaccines against Japanese encephalitis, West Nile fever and C. difficile.

"With an expanded board of directors and additional expertise we look forward to enhancing the support to FIND's mission to develop and introduce innovative diagnostics that are affordable, user-friendly, robust and rapid for use in resource limited settings," Kessel said.